Skip to content

A Study About Nutritional Support of Enhanced Protein in Critical Patients

A Multicenter Randomized Controlled Clinical Study With WeiYuan Tai (a Nutritional Supplement) on Nutritional Support of Enhanced Protein in Severe Patients(Tai Shan)

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04177446
Enrollment
180
Registered
2019-11-26
Start date
2019-12-25
Completion date
2020-05-31
Last updated
2019-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Keywords

national support, protein, critical illness

Brief summary

This is a prospective randomized controlled trial. 180 patients with critical illness will be included and randomly divided into two groups. In the control group, patients will be fed with basic energy; and in the experiment group, the patients will be given extra protein intake except the basic energy intake. The intervention duration will last 6 days. The primary outcomes of this study are urea nitrogen of 24h and prealbumin(PA). And other outcomes include nutritional status, safety indicators and clinical indicators.

Detailed description

Critical illness patients are commonly in the risk of malnutrition, because of various factors. And nutritional supplement, particularly the supplement of protein, can decrease the nitrogen balance, improve the nutritional status, accelerate the speed of healing and decrease the mortality rate. This is a multi center prospective randomized controlled trial. 180 patients with critical illness will be included and randomly divided into two groups. In the control group, patients will be fed with basic energy; and in the experiment group, the patients will be given extra protein intake except the basic energy intake. The intervention duration will last 6 days. The primary outcomes of this study are urea nitrogen of 24h and prealbumin(PA). And other outcomes include nutritional status(total protein, albumin, grip and calf circumference), safety indicators(liver function, kidney function, tolerance, etc.) and clinical indicators(overall complication rate, length of hospital stay and cost).

Interventions

DIETARY_SUPPLEMENTa production consist of various oligopeptides and the whey protein

patients will be given extra protein intake except the basic energy intake

DIETARY_SUPPLEMENTbasic energy intake

supplement as basic energy intake

DIETARY_SUPPLEMENTmaltodextrin

used as placebo in the control group

Sponsors

Yabao Pharmaceutical Group
CollaboratorINDUSTRY
The First Affiliated Hospital of Dalian Medical University
CollaboratorOTHER
The Second Affiliated Hospital of Dalian Medical University
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
Peking Union Medical College Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

1. diagnosed as critical illness, stayed in ICU; 2. score of M-nutric ≥ 5; 3. score of 3. APACHE Ⅱ \>12; 4. anticipation of length of hospital stay \> 6 days; 5. 18 ≤ age ≤ 45; 6. pattens volunteer to attend this study and sigh the inform consent form;

Exclusion criteria

1. liver function(AST/ALT) of blood test ≥ 2.5 ULN(upper limit of normal); renal function of blood test \> 1.6 ULN; 2. the patients are used or are planned to use the Human Albumin solution within 3 days before receiving enteral nutrition; 3. consume any natural food or something made by natural food; 4. patients are used or are planned to use all-in-one solution or amino acid solution within 3 days before receiving enteral nutrition; 5. anticipation of survival time is less than 5 days; 6. have the contraindications of enteral nutrition; 7. patients are allergic to material of the production; 8. patients who are considered not suitable for this study by investigators;

Design outcomes

Primary

MeasureTime frameDescription
urea nitrogen of 24hday6the total amount of urea nitrogen in 24 hours
prealbumin(PA)day6the level of prealbumin in blood

Secondary

MeasureTime frameDescription
overall complication ratefrom the day receiving enteral nutrition to day6the over complication rate after receiving enteral nutrition
total proteinday6the total protein level in blood
albuminday6the level of albumin in blood
length of hospital stayfrom date of admission in the hospital until the date of discharge, up to 1 yearthe overall time stay in hospital
cost in hospitalfrom date of admission in the hospital until the date of discharge, up to 1 yearall the money paid in the hospital
liver functionday6the level of AST/ALT in blood
renal functionday6the level of creatinine in blood
calf circumferencechange from baseline calf circumference at 6 daysthe perimeter of calf
gripchange from baseline grip at 6 daysthe strength(force measured kilograms) of the right hand measured by a hand-held dynamometer (if the right hand is not impossible, the left is ok )

Contacts

Primary ContactWei Chen
chenw@pumch.cn+86(010)69154095
Backup ContactZhangping Yu
yuzhangping1993@163.com+86(010)69154095

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026